Neonatal lipopolysaccharide treatment has long-term effects on monoaminergic and cannabinoid receptors in the rat.
Level 5 - mechanism / opinion, no new human data
Animal/bench research with no human data
PubMed 23389966 · doi:10.1002/syn.21640
What was done
Rats were treated with bacterial endotoxin lipopolysaccharide (LPS) on postnatal days 3 and 5. In adulthood (postnatal day 85), dopamine D1, D2, serotonin 5HT1A, 5HT2A, serotonin transporter, and cannabinoid CB1 receptor binding were measured autoradiographically across several brain regions.
What was found
The abstract reports directional statistical significance but provides no exact numbers, percentages, or effect sizes: - Significant increase in dopamine D2 receptor binding in the nucleus accumbens and olfactory tubercle. - Significant decrease in 5HT1A receptor binding in the hippocampus CA1 and ventromedial hypothalamus. - Significant decrease in CB1 receptor binding in the amygdala. - No significant impact on dopamine D1, serotonin 5HT2A, or serotonin transporter binding in any brain region examined.
Why it matters
It demonstrates that transient early-life inflammation can induce persistent, region-specific alterations in adult monoaminergic and cannabinoid receptor systems that may contribute to emotional and psychotic vulnerabilities.
Limits
Animal model without direct human translation. The abstract lacks sample sizes (n), LPS dosage details, sex distribution of animals, and numerical data or effect sizes. Functional behavioral outcomes were not measured.
Cited by
- partial Lipopolysaccharide (LPS) interferes with serotonin and dopamine binding in the brain.